loadpatents
Patent applications and USPTO patent grants for BioLineRx Ltd..The latest application filed is for "cxcr4 inhibitor for the treatment of acute respiratory distress syndrome and viral infections".
Patent | Date |
---|---|
Cxcr4 Inhibitor For The Treatment Of Acute Respiratory Distress Syndrome And Viral Infections App 20220288155 - STEIN; Gideon | 2022-09-15 |
Specific Combination Therapy For Treatment Of Pancreatic Cancer App 20220072087 - STEIN; Gideon ;   et al. | 2022-03-10 |
Treatment Of Metastatic Pancreatic Adenocarcinoma App 20220010016 - VAINSTEIN-HARAS; Abi ;   et al. | 2022-01-13 |
Methods Of Selecting Treatment For Cxcr4-associated Cancer App 20210338767 - BOHANA-KASHTAN; Osnat ;   et al. | 2021-11-04 |
Methods of treating acute myeloid leukemia Grant 10,993,985 - Pereg , et al. May 4, 2 | 2021-05-04 |
Agi-134 Combined With A Checkpoint Inhibitor For The Treatment Of Solid Tumors App 20210121491 - LEVY; Irit Carmi | 2021-04-29 |
Compositions, Articles Of Manufacture And Methods For Treating Cancer App 20200390855 - PELED; Amnon ;   et al. | 2020-12-17 |
Compositions, articles of manufacture and methods for treating cancer Grant 10,786,547 - Peled , et al. September 29, 2 | 2020-09-29 |
Compositions And Methods For Treating Cancer App 20200297803 - PELED; Amnon ;   et al. | 2020-09-24 |
Compositions And Methods For Treating Cancer App 20200297802 - PELED; Amnon ;   et al. | 2020-09-24 |
Compositions And Methods For Treating Cancer App 20200297804 - PELED; Amnon ;   et al. | 2020-09-24 |
Compositions And Methods For Treating Cancer App 20200297805 - PELED; Amnon ;   et al. | 2020-09-24 |
Compositions And Methods For Treating Cancer App 20200297809 - PELED; Amnon ;   et al. | 2020-09-24 |
Compositions And Methods For Treating Cancer App 20200297810 - PELED; Amnon ;   et al. | 2020-09-24 |
Compositions And Methods For Treating Cancer App 20200297811 - PELED; Amnon ;   et al. | 2020-09-24 |
Compositions And Methods For Treating Cancer App 20200297812 - PELED; Amnon ;   et al. | 2020-09-24 |
Compositions And Methods For Treating Cancer App 20200297808 - PELED; Amnon ;   et al. | 2020-09-24 |
Compositions And Methods For Treating Cancer App 20200297807 - PELED; Amnon ;   et al. | 2020-09-24 |
Compositions And Methods For Treating Cancer App 20200297806 - PELED; Amnon ;   et al. | 2020-09-24 |
Methods Of Treating Diseases Associated With Vascular Smooth Muscle Cell Proliferation App 20200282009 - PELED; Amnon | 2020-09-10 |
Compositions And Methods For Treating Cancer App 20200276267 - PELED; Amnon ;   et al. | 2020-09-03 |
Compositions And Methods For Treating Cancer App 20200268840 - PELED; Amnon ;   et al. | 2020-08-27 |
Compositions And Methods For Treating Cancer App 20200268841 - PELED; Amnon ;   et al. | 2020-08-27 |
Compositions And Methods For Treating Cancer App 20200268846 - PELED; Amnon ;   et al. | 2020-08-27 |
Compositions And Methods For Treating Cancer App 20200268845 - PELED; Amnon ;   et al. | 2020-08-27 |
Compositions And Methods For Treating Cancer App 20200268843 - PELED; Amnon ;   et al. | 2020-08-27 |
Compositions And Methods For Treating Cancer App 20200268844 - PELED; Amnon ;   et al. | 2020-08-27 |
Compositions And Methods For Treating Cancer App 20200268842 - PELED; Amnon ;   et al. | 2020-08-27 |
Compositions and methods for treating cancer Grant 10,682,390 - Peled , et al. | 2020-06-16 |
Methods Of Treating Acute Myeloid Leukemia App 20190046602 - PEREG; Yaron ;   et al. | 2019-02-14 |
Methods Of Treating Acute Myeloid Leukemia With A Flt3 Mutation App 20190038703 - PELED; Amnon ;   et al. | 2019-02-07 |
Methods Of Treating Myeloid Leukemia App 20180344801 - PELED; Amnon ;   et al. | 2018-12-06 |
Methods Of Treating Myeloid Leukemia App 20180311308 - PELED; Amnon ;   et al. | 2018-11-01 |
Cxcr4 Binding Agents For Treatment Of Diseases App 20180221393 - PELED; Amnon ;   et al. | 2018-08-09 |
Methods Of Obtaining Mononuclear Blood Cells And Uses Thereof App 20180161366 - PELED; Amnon ;   et al. | 2018-06-14 |
Compositions, Articles Of Manufacture And Methods For Treating Cancer App 20180140670 - PELED; Amnon ;   et al. | 2018-05-24 |
Compositions And Methods For Treating Cancer App 20180140660 - PELED; Amnon ;   et al. | 2018-05-24 |
Methods Of Mesenchymal Stem Cell Mobilization And Expansion App 20180142211 - PELED; Amnon ;   et al. | 2018-05-24 |
Methods Of Treating Acute Myeloid Leukemia With A Flt3 Mutation App 20160243187 - PELED; Amnon ;   et al. | 2016-08-25 |
Methods Of Treating Myeloid Leukemia App 20160082071 - PELED; Amnon ;   et al. | 2016-03-24 |
Crystalline Forms Of The Tri-mesylate Salt Of Perphenazine-gaba And Process Of Producing The Same App 20130150352 - NUDELMAN; Abraham ;   et al. | 2013-06-13 |
Crystalline forms of the tri-mesylate salt of perphenazine-GABA and process of producing the same Grant 8,377,929 - Nudelman , et al. February 19, 2 | 2013-02-19 |
Conjugates comprising a GABA- or glycine compound, pharmaceutical compositions and combinations thereof and their use in treating CNS disorders Grant 8,222,296 - Nudelman , et al. July 17, 2 | 2012-07-17 |
Method Of Promoting Muscle Tissue Repair App 20100216739 - Lifshitz; Ran ;   et al. | 2010-08-26 |
NCAGE Code | 3002A | BIOLINERX LTD |
NCAGE Code | SPV18 | BIOLINERX LTD |
CAGE Code | SPV18 | BIOLINERX LTD NEW PROJECT LTD - FORMERLY |
CAGE Code | 3002A | BIOLINERX LTD BIOLINE THERAPEUTICS LTD - FORMERLY |
S.A.M. Registration | 3002A [533746764] | BIOLINERX LTD BIOLINE THERAPEUTICS LTD - FORMERLY |
SEC | 0001498403 | BioLineRx Ltd. of ISRAEL |
SEC | 0001704335 | BioLineRx Ltd./ADR |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.